AMDL Launches New Updated Website at www.amdl.com
February 25 2008 - 8:46AM
PR Newswire (US)
TUSTIN, Calif., Feb. 25 /PRNewswire-FirstCall/ -- AMDL, Inc.
(AMEX:ADL), headquartered in Tustin, California, with operations in
Shenzhen, Jiangxi, and Jilin, China, through its wholly owned
subsidiary Jade Pharmaceutical Inc., is an international biopharma
company that, together with Jade, engages in the development,
manufacture and marketing of proprietary pharmaceutical, health
care and diagnostic products. The Company announced today that it
has an updated, improved website at http://www.amdl.com/ . Gary
Dreher, CEO of AMDL, noted that "our new website significantly
enhances and illuminates the compelling business that AMDL has
built and is continuing to expand. We encourage anyone interested
in gaining a better insight into our Company to visit
http://www.amdl.com/. Later this year we anticipate that the
websites for our Chinese subsidiaries and their products will also
be updated in both English and Chinese." The new web site details
all the Company's products, including cancer diagnostics, cancer
therapy, anti-aging treatments, nutraceuticals and other therapies.
It also provides information on the Company's management team, its
business strategies and future objectives. About Jade
Pharmaceutical Inc.: Jade has access to the fastest growing
pharmaceutical and consumer market in the world: China. AMDL,
through its subsidiaries, Jade currently manufactures large volume
injection fluids, tablets and other related products, holding
licenses for 133 products. Jade also manufactures 107 generic, over
the counter and supplemental pharmaceutical products under
certified Chinese Good Manufacturing Practice (CGMP) standards.
About AMDL: More information about AMDL and its products can be
obtained at http://www.amdl.com/. Forward-Looking Statements This
news release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. Such
statements are subject to certain risks and uncertainties, and
actual circumstances, events or results may differ materially from
those projected in such forward-looking statements. The Company
cautions readers not to place undue reliance on any forward-looking
statements. The Company does not undertake, and specifically
disclaims any obligation, to update or revise such statements to
reflect new circumstances or unanticipated events as they occur.
Contact: AMDL, Inc. Mr. Paul Knopick AMDL Investor Relations Direct
Line: 949.707.5365 VoiceMail: 714.505.4460 DATASOURCE: AMDL, Inc.
CONTACT: Mr. Paul Knopick, AMDL Investor Relations,
+1-949-707-5365, VoiceMail, +1-714-505-4460
Copyright
Amdl (AMEX:ADL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amdl (AMEX:ADL)
Historical Stock Chart
From Jul 2023 to Jul 2024